1-20 of 133
Funda Meric-Bernstam
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract 1202: A repository of PDX histology images for exploring spatial heterogeneity and cancer dynamics

Brian S. White, Xingyi Woo, Soner Koc, Todd Sheridan, Steven B. Neuhauser, Akshat M. Savaliya, Lacey E. Dobrolecki, John D. Landua, Matthew H. Bailey, Maihi Fujita, Kurt W. Evans, Bingliang Fang, Junya Fujimoto, Maria Gabriela Raso, Shidan Wang, Guanghua Xiao, Yang Xie, Sherri R. Davies, Ryan C. Fields, R Jay Mashl, Jacqueline L. Mudd, Yeqing Chen, Min Xiao, Xiaowei Xu, Melinda G. Hollingshead, Shahanawaz Jiwani, PDXNet Consortium, Yvonne A. Evrard, Tiffany A. Wallace, Jeffrey A. Moscow, James H. Doroshow, Nicholas Mitsiades, Salma Kaochar, Chong-xian Pan, Moon S. Chen, Luis G. Carvajal-Carmona, Alana L. Welm, Bryan E. Welm, Michael T. Lewis, Ramaswamy Govindan, Li Ding, Shunqiang Li, Meenhard Herlyn, Michael A. Davies, Jack A. Roth, Funda Meric-Bernstam, Carol J. Bult, Brandi Davis-Dusenbery, Dennis A. Dean, Jeffrey H. Chuang
Journal: Cancer Research
Cancer Res (2022) 82 (12_Supplement): 1202.
DOI: https://doi.org/10.1158/1538-7445.AM2022-1202
Published: 15 June 2022
View article
Journal Articles

Abstract 327: Antitumor efficacy of trastuzumab deruxtecan in combination with adavosertib in HER2-expressing Cyclin E amplified gastroesophageal cancers

Timothy P. DiPeri, Kurt W. Evans, Gabriela Raso, Yasmeen Q. Rizvi, Xiaofeng Zheng, Bryce Kirby, Kathleen Kong, Khandan Keyomarsi, Jaffer A. Ajani, Timothy A. Yap, Funda Meric-Bernstam
Journal: Cancer Research
Cancer Res (2022) 82 (12_Supplement): 327.
DOI: https://doi.org/10.1158/1538-7445.AM2022-327
Published: 15 June 2022
View article
Journal Articles

Abstract 3275: Bromodomain and extraterminal (BET) protein inhibition sensitize BRAFV600E colorectal cancer to standard targeted therapies

Hey Min Lee, Stefania Napolitano, Alexy Sorokin, Melanie N. Woods, Saikat Chowdhury, Jumanah Y. Alshenaifi, Anand K. Singh, John Paul Shen, Funda Meric-Bernstam, Kunal Rai, Scott Kopetz
Journal: Cancer Research
Cancer Res (2022) 82 (12_Supplement): 3275.
DOI: https://doi.org/10.1158/1538-7445.AM2022-3275
Published: 15 June 2022
View article
Journal Articles

Abstract 3107: Identifying therapeutic vulnerabilities in HR-positive, HER2-negative advanced breast cancer patient-derived xenograft models refractory to CDK4/6 inhibition

Nicole M. Kettner, Juliana Navarro-Yepes, Tuyen N. Bui, Xiayu Rao, Jing Wang, Funda Meric-Bernstam, Kelly K. Hunt, Debu Tripathy, Khandan Keyomarsi
Journal: Cancer Research
Cancer Res (2022) 82 (12_Supplement): 3107.
DOI: https://doi.org/10.1158/1538-7445.AM2022-3107
Published: 15 June 2022
View article
Journal Articles

Abstract 1588: Discordance of HER2 expression and/or amplification on repeat testing

Timothy D. DiPeri, Kathleen Kong, Daniel D. Karp, Jaffer A. Ajani, Shubham Pant, Sarina A. Piha-Payl, Ecaterina E. Dumbrava, Funda Meric-Bernstam
Journal: Cancer Research
Cancer Res (2022) 82 (12_Supplement): 1588.
DOI: https://doi.org/10.1158/1538-7445.AM2022-1588
Published: 15 June 2022
View article
Journal Articles

Abstract 1791: Epigenetically upregulating TROP2 enhances therapeutic efficacy of TROP2 ADC sacitizumab govitecan

Ming Zhao, Timothy P. DiPeri, Gabriela Raso, Yasmeen Q. Rizvi, Xiaofeng Zheng, Kurt Evans, Argun Akcakanat, Fei Yang, Debu Tripathy, Ecaterina Ileana Dumbrava, Senthil Damodaran, Funda Meric-Bernstam
Journal: Cancer Research
Cancer Res (2022) 82 (12_Supplement): 1791.
DOI: https://doi.org/10.1158/1538-7445.AM2022-1791
Published: 15 June 2022
View article
Journal Articles

Abstract 1792: FGFR3 mediated PARP1 tyrosine 158 phosphorylation promotes PARP inhibitor resistance

MeiKuang Chen, Yuan Gao, Weiya Xia, Yu-Han Wang, Jennifer K. Litton, Yu-Yi Chu, Funda Meric-Bernstam, Helen Piwnica-Worms, Banu Arun, Jordi Rodon Ahnert, Yongkun Wei, Wei-Chao Chang, Hung-Ling Wang, Coya Tapia, Constance T. Albarracin, Shao-Chun Wang, Ying-Nai Wang, Gabriel N. Hortobagyi, Chunru Lin, Liuqing Yang, Dihua Yu, Mien-Chie Hung
Journal: Cancer Research
Cancer Res (2022) 82 (12_Supplement): 1792.
DOI: https://doi.org/10.1158/1538-7445.AM2022-1792
Published: 15 June 2022
View article
Journal Articles

Abstract CT110: Olaparib (O) in patients (pts) with solid tumors with ATM mutation or deletion: Results from the Targeted Agent and Profiling Utilization Registry (TAPUR) Study

Kathryn F. Mileham, Michael Rothe, Pam K. Mangat, Elizabeth Garrett-Mayer, Eddy S. Yang, Olatunji B. Alese, Angela Jain, Herbert L. Duvivier, Phillip Palmbos, Eugene R. Ahn, Jeanny B. Aragon-Ching, Kathleen W. Beekman, Deepti Behl, Funda Meric-Bernstam, Rodolfo Gutierrez, Amy Sanford, Ramya Thota, Michael Zakem, Song Zhao, Raegan O'Lone, Gina N. Grantham, Susan Halabi, Richard L. Schilsky
Journal: Cancer Research
Cancer Res (2022) 82 (12_Supplement): CT110.
DOI: https://doi.org/10.1158/1538-7445.AM2022-CT110
Published: 15 June 2022
View article
Journal Articles

Abstract CT029: Safety and clinical activity of single-agent ZN-c3, an oral WEE1 inhibitor, in a phase 1 trial in subjects with recurrent or advanced uterine serous carcinoma (USC)

Funda Meric-Bernstam, Pavani Chalsani, Hirva Mamdani, Cheng Zheng, Marcus Viana, Ruth Lambersky, Philippe Pultar, Anthony W. Tolcher
Journal: Cancer Research
Cancer Res (2022) 82 (12_Supplement): CT029.
DOI: https://doi.org/10.1158/1538-7445.AM2022-CT029
Published: 15 June 2022
View article
Journal Articles

Abstract CT032: Activity and safety of alectinib for ALK-altered solid tumors from MyPathway

Charles Swanton, Claire F. Friedman, Christopher J. Sweeney, Funda Meric-Bernstam, David Spigel, Ron Bose, Howard Burris, Walter C. Darbonne, Julia Malato, Jonathan Levy, Yong Wang, Tania Szado, Katja Schulze, John Hainsworth, Razelle Kurzrock
Journal: Cancer Research
Cancer Res (2022) 82 (12_Supplement): CT032.
DOI: https://doi.org/10.1158/1538-7445.AM2022-CT032
Published: 15 June 2022
View article
Journal Articles

Abstract 1768: Anti-tumor activity and biomarker analysis for datopotamab deruxtecan in breast cancer PDX models

Erkan Yuca, Kurt Evans, Argun Akcakanat, Gabriela Raso, Yasmeen Q. Rizvi, Fei Yang, Lauren Byers, Senthil Damodaran, Okajima Daisuke, Funda Meric-Bernstam
Journal: Cancer Research
Cancer Res (2022) 82 (12_Supplement): 1768.
DOI: https://doi.org/10.1158/1538-7445.AM2022-1768
Published: 15 June 2022
View article
Journal Articles

Abstract 5152: Mutation-agnostic detection of colorectal cancer-specific cell-free DNA using targeted methylation sequencing

Mohamed A. Gouda, Dzifa Y. Duose, Morten Lapin, Stephanie Zalles, Helen J. Huang, Yuanxin Xi, Xiaofeng Zheng, Amira I. Aldesoky, Alshimaa M. Alhanafy, Mohamed A. Shehata, Jing Wang, Scott Kopetz, Funda Meric-Bernstam, Ignacio I. Wistuba, Rajyalakshmi Luthra, Filip Janku
Journal: Cancer Research
Cancer Res (2022) 82 (12_Supplement): 5152.
DOI: https://doi.org/10.1158/1538-7445.AM2022-5152
Published: 15 June 2022
View article
Journal Articles

Abstract 5237: B-Raf V600E harboring non-melanoma cancers treated with Vemurafenib monotherapy and in combination with Everolimus/Sorafenib/Crizotinib/Paclitaxel+ Carboplatin: A pooled analysis of five phase 1/2 studies

Blessie Elizabeth Nelson, Jason Roszik, Filip Janku, David Hong, Shumei Kato, Aung Naing, Sarina Piha-Paul, Siqing Fu, Apostolia Tsimberidou, Maria Cabanillas, Naifa Busaidy, Milind Javle, Lauren Byers, John Heymach, Funda Meric-Bernstam, Vivek Subbiah
Journal: Cancer Research
Cancer Res (2022) 82 (12_Supplement): 5237.
DOI: https://doi.org/10.1158/1538-7445.AM2022-5237
Published: 15 June 2022
View article
Journal Articles

Abstract 2618: Convergent MAPK pathway alterations mediate acquired resistance to FGFR inhibitors in cholangiocarcinoma with FGFR fusions/rearrangements

TImothy P. DiPeri, Ming Zhao, Tyler Moss, Michael Kahle, Payal Rauli, Sunyoung S. Lee, Abdel Halim, Hiroshi Hirai, Volker Wacheck, Karim Benhadji, Jordi Rodon, Milind Javle, Funda Meric-Bernstam
Journal: Cancer Research
Cancer Res (2022) 82 (12_Supplement): 2618.
DOI: https://doi.org/10.1158/1538-7445.AM2022-2618
Published: 15 June 2022
View article
Journal Articles

Abstract 6088: Reconstructing mutational lineages in breast cancer by multi-patient-targeted single cell DNA sequencing

Jake Leighton, Min Hu, Emi Sei, Funda Meric-Bernstam, Nicholas Navin
Journal: Cancer Research
Cancer Res (2022) 82 (12_Supplement): 6088.
DOI: https://doi.org/10.1158/1538-7445.AM2022-6088
Published: 15 June 2022
View article
Journal Articles

Abstract P5-08-12: Efficacy of futibatinib, an irreversible fibroblast growth factor receptor (FGFR) inhibitor, in breast cancer models with FGFR alterations

Turcin Saridogan, Argun Akcakanat, Ming Zhao, Kurt W. Evans, Erkan Yuca, Stephen Scott, Bryce P. Kirby, Xiaofeng Zheng, Senthil Damodaran, Funda Meric-Bernstam
Journal: Cancer Research
Cancer Res (2022) 82 (4_Supplement): P5-08-12.
DOI: https://doi.org/10.1158/1538-7445.SABCS21-P5-08-12
Published: 15 February 2022
View article
Journal Articles

Abstract GS2-07: Updated results from a phase 3 randomized clinical trial in participants (pts) with 1-3 positive lymph nodes (LN), hormone receptor-positive (HR+) and HER2-negative (HER2-) breast cancer (BC) with recurrence score (RS) ≤ 25 randomized to endocrine therapy (ET) +/- chemotherapy (CT): SWOG S1007 (RxPONDER)

Kevin M Kalinsky, William E Barlow, Julie R Gralow, Funda Meric-Bernstam, Kathy S Albain, Daniel F Hayes, Nancy U Lin, Edith A Perez, Lori A Goldstein, Stephen KL Chia, Sukhbinder Dhesy-Thind, Priya Rastogi, Emilio Alba, Suzette Delaloge, Miguel Martin, Catherine M Kelly, Manuel Ruiz-Borrego, Miguel Gil-Gil, Claudia H Arce-Salinas, Etienne GC Brain, Eun Sook Lee, Jean-Yves Pierga, Begoña Bermejo, Manuel Ramos-Vasquez, Kyung Hae Jung, Jean-Marc Ferrero, Anne Schott, Steven Shak, Priyanka Sharma, Danika Lew, Jieling Miao, Debasish Tripathy, Lajos Pusztai, Gabriel Hortobagyi
Journal: Cancer Research
Cancer Res (2022) 82 (4_Supplement): GS2-07.
DOI: https://doi.org/10.1158/1538-7445.SABCS21-GS2-07
Published: 15 February 2022
View article
Journal Articles

Abstract OT1-14-01: Zanidatamab in combination with ALX148 in advanced human epidermal growth factor receptor 2 (HER2)-expressing cancers, including breast cancer: A phase 1b/2, multicenter, open-label, dose-finding and cohort-expansion study (ZWI-ZW25-204)

Sara A. Hurvitz, Jorge Chaves, Adam Brufsky, Alberto J. Montero, Bruno Fang, Kay Yeung, Manish R. Patel, Ritesh Parajuli, Adam Omidpanah, Elaina Gartner, Abraham Fong, Sophia Randolph, Funda Meric-Bernstam
Journal: Cancer Research
Cancer Res (2022) 82 (4_Supplement): OT1-14-01.
DOI: https://doi.org/10.1158/1538-7445.SABCS21-OT1-14-01
Published: 15 February 2022
View article
Journal Articles

Abstract P2-13-07: Zanidatamab (ZW25), a HER2-targeted bispecific antibody, in combination with chemotherapy (chemo) for HER2-positive breast cancer (BC): Results from a phase 1 study

Philippe L Bedard, Seock-Ah Im, Elena Elimova, Sun Young Rha, Rachel Goodwin, Cristiano Ferrario, Keun-Wook Lee, Diana Hanna, Funda Meric-Bernstam, Jose Mayordomo, Murali Beeram, Erika Hamilton, Jorge Chaves, Melody Cobleigh, Tony Mwatha, Joseph Woolery, Do-Youn Oh
Journal: Cancer Research
Cancer Res (2022) 82 (4_Supplement): P2-13-07.
DOI: https://doi.org/10.1158/1538-7445.SABCS21-P2-13-07
Published: 15 February 2022
View article
Journal Articles

Abstract GS1-05: Datopotamab deruxtecan in advanced/metastatic HER2- breast cancer: Results from the phase 1 TROPION-PanTumor01 study

Ian Krop, Dejan Juric, Toshio Shimizu, Anthony Tolcher, Alexander Spira, Toru Mukohara, Aaron E. Lisberg, Takahiro Kogawa, Kyriakos P. Papadopoulos, Erika Hamilton, Senthil Damodaran, Jonathan Greenberg, Wen Gu, Fumiaki Kobayashi, Ferdinand Guevara, Takahiro Jikoh, Yui Kawasaki, Funda Meric-Bernstam, Aditya Bardia
Journal: Cancer Research
Cancer Res (2022) 82 (4_Supplement): GS1-05.
DOI: https://doi.org/10.1158/1538-7445.SABCS21-GS1-05
Published: 15 February 2022
View article